Future Journal of Pharmaceutical Sciences

Table 11 Peroxide peak results

From: Development and validation of stability indicating UPLC method for the simultaneous estimation of triamterene and hydrochlorothiazide in combined dosage forms using quality by design approach

	Sample	Retention time	Area	Height	Tailing	Plate count	Purity1 angle	Purity1 threshold
01	Peak1	0.067
02		0.534	187	260	1.32	4940.33
03	Triamterene	0.918	811,590	305,421	1.72	2381.52	0.292	0.391
04	Peak3	1.285
05		1.385	25,714	7887	1.16	3802.83	1.274	1.777
06	Peak4	1.543	36,867	8718		3957.11	15.224	1.501
07	HCTZ	1.736	917,267	230,369	1.32	4198.72
08	Peak6	2.516
09		3.700	87	174	1.00	386,435.81
10	Peak7	4.134
11	Peak8	5.817

Back to article page